MedTrace Logo

Promoting Asylum-seeking and Refugee Children's Coping With Trauma

NCT03822598 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2019-01-30

No results posted yet for this study

Summary

A short term trauma-focused cognitive- behavioral program to reduce trauma-related mental health problems among asylum-seeking and refugee children.

The main hypothesis of the study is that the TRT program significantly improves mental health (i.e. reduces symptoms of post-traumatic symptoms, depression and generalized anxiety and increases perceived quality of life (Qol) in the intervention group compared to the waiting-list control group.

Conditions

  • Mental Health Disorder
  • Post-Traumatic Stress Disorder in Adolescence
  • Depression
  • Social Anxiety

Interventions

BEHAVIORAL

Teaching Recovery Techniques, TRT

TRT is a , low-threshold, group based, manual driven short term intervention to reduce trauma-related mental health problems. The program is based on principles from trauma-focused cognitive-behavioral therapy

Sponsors & Collaborators

  • University of Tromso

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • Norwegian Directorate of Children, Youth, and Family Affairs

    collaborator UNKNOWN

  • Norwegian Directorate of Immigration

    collaborator UNKNOWN

  • Norwegian Directorate of Integration and Diversity

    collaborator UNKNOWN

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
8 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2018-05-31
Completion
2018-06-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03822598 on ClinicalTrials.gov